| microRNA-21 modulates cell proliferation and sensitivity to doxorubicin in bladder cancer cells. | bladder, |
| MicroRNA-21 induces cell proliferation and invasion in esophageal squamous cell carcinoma. | esophageal, |
| Downregulation of Pdcd4 by mir-21 facilitates glioblastoma proliferation in vivo. | glioblastoma, |
| MiR-21 is involved in cervical squamous cell tumorigenesis and regulates CCL20. | cervical, |
| MicroRNA-21 induces stemness by downregulating transforming growth factor beta receptor 2 (TGFbetaR2) in colon cancer cells. | colorectal, |
| MicroRNA-21 inhibits Serpini1, a gene with novel tumour suppressive effects in gastric cancer. | gastric, |
| DNA damage induces NF-kappaB-dependent microRNA-21 up-regulation and promotes breast cancer cell invasion. | breast, |
| these results reveal a regulatory interplay between miR-21, JAG1 and E2 that is important for advancing understanding of how the oncogenic potential of miR-21 and JAG1 manifests in different sub-types of breast cancer. | breast, |
| miR-21, miR-17 and miR-19a induced by phosphatase of regenerating liver-3 promote the proliferation and metastasis of colon cancer. | colorectal,liver, |
| microRNA-21 governs TORC1 activation in renal cancer cell proliferation and invasion. | kidney, |
| Co-inhibition of microRNA-10b and microRNA-21 exerts synergistic inhibition on the proliferation and invasion of human glioma cells. | glioma, |
| The oncogenic microRNA OncomiR-21 overexpressed during Marek s disease lymphomagenesis is transactivated by the viral oncoprotein Meq. | lymphoma, |
| Mutation of mir-21 might be involved in the oncogenesis and differentiation of laryngeal squamous cell carcinoma. | laryngeal, |
| microRNA 21-mediated suppression of Sprouty1 by Pokemon affects liver cancer cell growth and proliferation. | liver, |
| Results suggest that the AR and miR-21 axis exerts its oncogenic effects in prostate tumors by downregulating TGFBR2, hence inhibiting the tumor-suppressive activity of TGFbeta pathway. | prostate, |
| MicroRNA-21 may play an oncogenic role by directly targeting programmed cell death (PDCD)4 in the cellular processes of papillary thyroid carcinoma. | thyroid, |
| Data indicate insulin-like growth factor (IGF)-binding protein-3 (IGFBP3) as a miR-21 target gene in glioblastoma and suggest that the oncogenic miRNA miR-21 down-regulates the expression of IGFBP3, which acts as a tumor suppressor in human glioblastoma. | glioblastoma, |
| This report shows that p57(Kip2) is a novel target of miR-21 in prostate cancer and revealing a novel oncogenic function of this microRNA. | prostate, |
| Data show that microRNA miR-21 plays an oncogenic role in diffuse large B-cell lymphoma (DLBCL) by modulating the PI3-Kinase/AKT protein/mTOR protein/forkhead box O1 protein (FOXO1) pathway at multiple levels resulting in strong prognostic implication. | lymphoma, |
| microRNA-21 (miR-21) acts as an oncogenic driver of Clear cell renal cell carcinoma. | kidney, |